Company profile: Siegfried
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing for active pharmaceutical ingredients and drug products, including intermediates and controlled substances. Services span process development and optimization, formulation and pilot-scale production, registration support, and packaging and logistics for tablets, capsules, sterile vials, ampoules, cartridges, and ointments.
Products and services
- Contract Development and Manufacturing of Drug Products: Siegfried architects and produces finished dosage forms—tablets, capsules, sterile vials, ampoules, cartridges, and ointments—covering development through production, with sterile-capable handling
- Contract Development and Manufacturing of APIs: Siegfried engineers active pharmaceutical ingredients and related intermediates, including controlled substances, delivering end-to-end services from process development to production at industrial-scale
- Process Development and Optimization: Siegfried develops and optimizes pharmaceutical manufacturing processes to enhance efficiency and scalability, offering process development and optimization services with a scalability-focused approach
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Siegfried
Ritedose
HQ: United States
Website
- Description: Provider of pharmaceutical products and services focused on the respiratory market. A leader in blow-fill-seal (BFS) manufacturing of small-fill unit dose sterile and non-sterile liquids for inhalation and ophthalmic use. Offers 503B outsourcing with pre-filled, ready-to-use syringes for hospitals and generic inhalation solutions including cromolyn sodium, albuterol sulfate, and arformoterol tartrate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ritedose company profile →
STATinMED
HQ: United States
Website
- Description: Provider of health economics and outcomes research, real-world evidence consulting, and market access services for life science companies. Offers RWD Insights Direct using de-identified medical and pharmacy claims data, Custom Registry aligning patient, provider, payer, disease, and outcome data to evidence and strategy, and produces peer-reviewed publications across therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full STATinMED company profile →
Voyageur Pharmaceuticals
HQ: Canada
Website
- Description: Provider of mining-based pharmaceutical products and imaging contrast agents for medical radiology, producing barite and iodine APIs for barium contrast applications (x-radiation, CT, MRI), including SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD GI barium suspensions/powders, and V-Gas, an under-development antacid/antiflatulent for double contrast studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Voyageur Pharmaceuticals company profile →
Fidia Pharma
HQ: Italy
Website
- Description: Provider of hyaluronic acid–based therapies for joint health, tissue repair, wound healing, ophthalmology, and aesthetic care, plus autologous biological therapy. Offers ophthalmic products (contact lenses, lens solutions, eye drops), gynaecological medicines (anti-infectives, ovarian stimulants), and treatments for skin lesions to restore the skin barrier. Italian multinational with R&D, manufacturing, marketing and sales capabilities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fidia Pharma company profile →
Biorasi
HQ: United States
Website
- Description: Provider of contract research services for complex clinical trials, offering safety and pharmacovigilance (medical coding, case processing, data monitoring, safety management, annual reporting), clinical trial rescue (patient recruitment, site activation, logistical coordination), CAR T-cell therapy trial management (cell collection, modification, reinfusion), and precision medicine through pharmacogenomics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biorasi company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Siegfried
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Siegfried
2.2 - Growth funds investing in similar companies to Siegfried
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Siegfried
4.2 - Public trading comparable groups for Siegfried
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →